Ciraparantag

ciraparantag · Perosphere Pharmaceuticals Inc, a subsidiary of AMAG Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Ciraparantag, covering 2025-09-02 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of Ciraparantag for Reversal of Anticoagulation Induced by Edoxaban, Apixaban or Rivaroxaban in Healthy Adults [Phase 2]

See pricing